Although neutralization of IL-17A was not effective in the relief of colitis in a mouse model [25] or in a clinical study of CD patients [26], another Th17-type cytokine, IL-21, also has pro-inflammatory effects and may be a suitable therapeutic target [20]. This evidence concerns the gene IL21 and colitis.